The immune contexture in human tumours: impact on clinical outcome
about
Cancer classification using the Immunoscore: a worldwide task forceMolecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseThe significance of tumor-associated immune response in molecular taxonomy, prognosis and therapy of colorectal cancer patientsTowards tumor immunodiagnosticsBiosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLORegulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingTertiary Lymphoid Organs in Cancer TissuesNeural regulation of cancer: from mechanobiology to inflammationTargeting microRNAs as key modulators of tumor immune responseImmunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsFrom bench to bedside a comprehensive review of pancreatic cancer immunotherapy.Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host SurvivalAssociation of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancerThe fate of chemoresistance in triple negative breast cancer (TNBC)Gastric cancer: The times they are a-changin'Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissuesAdvances in immunotherapy for treatment of lung cancerImmunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigationsImmune cell interplay in colorectal cancer prognosisImmunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsTargeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityCancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant StateInterest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccinePrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerStromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic TargetControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentTherapeutic Lymphoid Organogenesis in the Tumor MicroenvironmentGenetic instability in the tumor microenvironment: a new look at an old neighborUnderstanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpointsMyeloid Cells as Targets for Therapy in Solid TumorsThe gastrointestinal tumor microenvironmentMast cells as a potential prognostic marker in prostate cancerEtiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionRole of TH17 cytokines in the control of colorectal cancerToll-like Receptors in Ovarian Cancer as Targets for ImmunotherapiesControl of the immune response by pro-angiogenic factorsDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyCharacteristics of tertiary lymphoid structures in primary cancersCancer vaccines
P2860
Q21245495-6973CBE2-B80C-4E68-868F-0BA12A6DB3CCQ24289344-0A247168-38F3-44AB-9E46-13DB360EB4DCQ26738665-0D088EE4-C505-4583-AB57-0D2F2F96C668Q26738691-832B0645-928C-49F1-87CE-4F698C9EC7A6Q26739445-3CE5727D-E946-4C93-9AAE-6C389CA06083Q26742012-01670AE1-C9D0-4848-A50C-21472F9EB452Q26742168-9C3EFAA9-842C-42C7-9CAA-12C5F671667FQ26746714-EA554197-C715-439F-A231-59C8C032091BQ26746972-C012A59A-E7E7-4DA0-B630-68AC3744530EQ26765115-6877C3AE-45A7-4CA1-A718-4D03C3E6D7CBQ26765123-CED81A9C-87FD-4BC9-B75C-6CCCFD0E0DAEQ26765429-42FF7E9C-9E15-4325-8E46-85F91E2FBBADQ26773212-0FAF7F4D-5908-4B2D-A6AE-23935DD6A98FQ26774690-8E00E8E1-094B-4A7E-9264-B452104E0D64Q26775232-88D93D41-0FFA-435A-94D6-0DE45F9CDB7FQ26776195-C8760FBA-E222-479B-BF42-39C0DB4B7405Q26778348-96BDCB2A-48CE-4971-ADA8-E75037A7D70FQ26778790-2DF59518-6696-4981-B7E7-24573895950BQ26781038-A67C331B-CCCE-46F0-99FD-B2FCD46EF2BEQ26781453-A515794D-7CEA-40AB-9AE9-8725D1E38792Q26781538-E2E0403F-7D1B-4569-B08F-B709F2A8E7CDQ26782201-5E8BE1C1-DCA0-4496-BB3B-B8FDB53E9771Q26782573-B7F43C7E-ED22-484C-8517-497D6D71E052Q26782583-3506B598-331C-4AED-BA33-B6C5EF30D621Q26795466-FCB31E29-232A-476E-BB0D-F4ACA56575D7Q26797288-B2928664-FD39-4041-BBF3-E579F3A05019Q26799117-E6E9C495-0379-46B4-A403-E64CC2D3B69BQ26799123-22FCC7B6-A726-424B-8959-D1C627BECD30Q26801374-7BA5442A-0252-42B2-A97F-740359754E37Q26801551-D67523EA-E0F2-4B47-8486-4DB41A73738DQ26801832-2B067816-3149-4391-8B1D-0A8AAD00AEBDQ26827391-AE3BDAC2-DB29-4263-882F-BC435AB5C1FEQ26827773-3DCFE269-D6CC-4E35-AC34-7BBA027AD1D2Q26852716-7B70082F-3C3E-47D8-A8E3-15F3D73307BDQ26860784-36B648E1-4194-41DD-A872-E66D4528B1C1Q26861234-2393F0AE-F907-41C2-BC1A-E9EE6FB25643Q27004733-ACAD9BF9-CDA2-47DE-AD6D-D802477AD215Q27011884-55A3B858-08EE-4D85-970A-A96C8B9E1105Q27012852-3532E356-371E-432D-96E6-74824D7346B1Q27024438-6F222BFA-089B-4503-BBFA-B7F71B16A015
P2860
The immune contexture in human tumours: impact on clinical outcome
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The immune contexture in human tumours: impact on clinical outcome
@ast
The immune contexture in human tumours: impact on clinical outcome
@en
type
label
The immune contexture in human tumours: impact on clinical outcome
@ast
The immune contexture in human tumours: impact on clinical outcome
@en
prefLabel
The immune contexture in human tumours: impact on clinical outcome
@ast
The immune contexture in human tumours: impact on clinical outcome
@en
P2093
P3181
P356
P1476
The immune contexture in human tumours: impact on clinical outcome
@en
P2093
Fridman WH
Sautès-Fridman C
P2888
P304
P3181
P356
10.1038/NRC3245
P407
P50
P577
2012-03-15T00:00:00Z
P5875
P6179
1034518617